1044871-54-6

Basic information

• Product Name: 2-(4-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methoxyphenoxy)acetic acid
• Synonyms: 2-(4-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methoxyphenoxy)acetic acid
• CAS NO: 1044871-54-6
• Molecular Weight: 386.361
• Mol File: 1044871-54-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-(4-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methoxyphenoxy)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methoxyphenoxy)acetic acid(1044871-54-6)
• EPA Substance Registry System: 2-(4-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methoxyphenoxy)acetic acid(1044871-54-6)

Safety Data

• Hazardous Substances Data: 1044871-54-6(Hazardous Substances Data)

Upstream product

• 10272-07-8 3.5-dimethoxyaniline 
• 40891-33-6 3,5-dimethoxyaniline hydrochloride 
• 121-33-5 vanillin 
• 63920-73-0 2-amino-4,6-dimethoxybenzamide 
• 1660-19-1 (4-formyl-2-methoxyphenoxy)acetic acid 
• 21544-81-0 4,6-dimethoxyindoline-2,3-dione 

Relevant articles and documents

TREATMENT OF DISEASES BY EPIGENETIC REGULATION

The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of cancer, including NUT midline carcinoma, Burkitt's Lymphoma, Acute Myelogenous Leukemia, and Multiple Myeloma; autoimmune or inflammatory diseases or conditions, and sepsis.